Published in Chest on October 01, 2000
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax (2004) 2.78
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax (2004) 2.54
Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax (2006) 2.46
Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis (2012) 1.87
Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J Chron Obstruct Pulmon Dis (2008) 1.66
Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med (2011) 1.65
Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax (2005) 1.58
Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes (2006) 1.49
[The prevalence of COPD in Austria--the expected change over the next decade]. Wien Klin Wochenschr (2007) 1.43
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med (2011) 1.25
Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health (2011) 1.24
Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract (2004) 1.20
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. Open Heart (2014) 1.20
Comorbidities and burden of COPD: a population based case-control study. PLoS One (2013) 1.17
Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 1.14
Prevalence of obstructive lung disease in a general population sample: the NICECOPD study. Eur J Epidemiol (2005) 1.14
Evaluation of pulmonary function and quality of life in women with osteoporosis. Osteoporos Int (2005) 1.14
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail (2009) 1.13
Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France. J Med Genet (2006) 1.12
Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis (2007) 1.09
Geographic variations in risk: adjusting for unmeasured confounders through joint modeling of multiple diseases. Epidemiology (2009) 1.07
Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health (2015) 1.06
Diagnosis and early detection of COPD using spirometry. J Thorac Dis (2014) 1.05
Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status. Lung (2011) 1.04
Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors. Int J Chron Obstruct Pulmon Dis (2010) 1.02
Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study feasibility. BMC Med Inform Decis Mak (2015) 1.01
Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry (2004) 0.99
Health-related quality of life in outpatients with COPD in daily practice: the VICE Spanish Study. Int J Chron Obstruct Pulmon Dis (2008) 0.99
What proportion of lung cancer in never-smokers can be attributed to known risk factors? Int J Cancer (2012) 0.98
Geographic differences in clinical characteristics and management of COPD: the EPOCA study. Int J Chron Obstruct Pulmon Dis (2008) 0.98
Misdiagnosis of patients receiving inhaled therapies in primary care. Int J Chron Obstruct Pulmon Dis (2010) 0.98
Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis. Thorax (2006) 0.97
Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences. Int J Chron Obstruct Pulmon Dis (2008) 0.96
Assessment of five different guideline indication criteria for spirometry, including modified GOLD criteria, in order to detect COPD: data from 5,315 subjects in the PLATINO study. NPJ Prim Care Respir Med (2014) 0.96
Determinants and predictors of the cost of COPD in primary care: a Spanish perspective. Int J Chron Obstruct Pulmon Dis (2008) 0.96
Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia. Ann Saudi Med (2011) 0.96
Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries. Int J Chron Obstruct Pulmon Dis (2014) 0.96
Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life. BMC Public Health (2009) 0.93
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.92
The Saudi Guidelines for the Diagnosis and Management of COPD. Ann Thorac Med (2014) 0.92
PLATINO, a nine-year follow-up study of COPD in the city of São Paulo, Brazil: the problem of underdiagnosis. J Bras Pneumol (2014) 0.92
Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract (2009) 0.91
Awareness of chronic obstructive pulmonary disease in current smokers: a nationwide survey. Korean J Intern Med (2015) 0.90
Prevalence of chronic cough, chronic phlegm & associated factors in Mysore, Karnataka, India. Indian J Med Res (2011) 0.90
Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea. Int J Chron Obstruct Pulmon Dis (2015) 0.89
Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study. BMC Pulm Med (2011) 0.88
Factors associated with hospital admission in patients reaching the emergency department with COPD exacerbation. Multidiscip Respir Med (2012) 0.88
The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. BMC Cardiovasc Disord (2010) 0.87
Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test. PLoS One (2015) 0.87
Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies. Int J Chron Obstruct Pulmon Dis (2009) 0.86
Investigating indicators and determinants of asthma in young adults. Eur J Epidemiol (2006) 0.84
Prevalence of COPD and tobacco smoking in Tunisia--results from the BOLD study. Int J Environ Res Public Health (2013) 0.84
Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea. BMC Pulm Med (2014) 0.83
Prevalence of chronic airflow limitation in Kashmir, North India: results from the BOLD study. Int J Tuberc Lung Dis (2016) 0.83
Different labelling of obstructive airway diseases in Estonia, Finland, and Sweden. Eur J Epidemiol (2005) 0.83
Clinical significance in COPD patients followed in a real practice. Multidiscip Respir Med (2013) 0.80
Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease. BMC Public Health (2009) 0.80
Prevalence of chronic obstructive pulmonary disease in kocaeli: an industrialised city in Turkey. Balkan Med J (2013) 0.79
Effectiveness of regular reporting of spirometric results combined with a smoking cessation advice by a primary care physician on smoking quit rate in adult smokers: a randomized controlled trial. ESPIROTAB study. BMC Fam Pract (2011) 0.79
Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study. Int J Chron Obstruct Pulmon Dis (2015) 0.79
Diagnosis of chronic obstructive pulmonary disease in the primary care setting. Hippokratia (2012) 0.79
The efficacy of spirometry as a screening tool in detection of air flow obstruction. Open Respir Med J (2010) 0.78
VitalQPlus: a potential screening tool for early diagnosis of COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.78
Usefulness of inspiratory capacity measurement in COPD patients in the primary care setting. Int J Gen Med (2009) 0.78
Use of spirometry among chest physicians and primary care physicians in India. NPJ Prim Care Respir Med (2016) 0.77
Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study. BMC Public Health (2009) 0.76
Spirometric testing on World COPD Day. Int J Chron Obstruct Pulmon Dis (2011) 0.76
Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care. Int J Chron Obstruct Pulmon Dis (2009) 0.76
Short-term outcomes in heart failure patients with chronic obstructive pulmonary disease in the community. World J Cardiol (2012) 0.76
Role of oxidative stress & transient receptor potential in chronic obstructive pulmonary disease. Indian J Med Res (2015) 0.75
Trend of cost and utilization of COPD medication in Korea. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI). BMC Pulm Med (2013) 0.75
Economic valuation and determinants of informal care to disabled people with Chronic Obstructive Pulmonary Disease (COPD). BMC Health Serv Res (2015) 0.75
COPD in Nonsmokers: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease Study. PLoS One (2016) 0.75
Voluntary pulmonary function screening with GOLD standard: an effective and simple approach to detect lung obstruction. J Thorac Dis (2015) 0.75
Pulmonary Function and Incidence of Selected Respiratory Diseases Depending on the Exposure to Ambient PM10. Int J Mol Sci (2016) 0.75
A comparative study of COPD burden between urban vs rural communities in northern Thailand. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Development and results of the Spanish registry of patients with alpha-1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis (2007) 0.75
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax (2003) 4.53
Letter: Collapse after prazosin hydrochloride. Lancet (1975) 4.21
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Picking up the tab for erythropoietin. BMJ (1991) 3.21
Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med (2001) 3.19
The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis (2001) 2.50
Audit of outpatient letters. BMJ (1991) 2.43
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer (2001) 2.26
[Hematocolpos due to obstructed hemivagina. About three cases]. Gynecol Obstet Fertil (2006) 2.11
[The use of human gamma globulin in the treatment of common variable immunodeficiency]. Med Clin (Barc) (1995) 2.04
Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J (2009) 1.90
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J (2003) 1.84
Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther (2001) 1.80
Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J (2010) 1.78
Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare. Int J Clin Pract (2008) 1.74
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia (2010) 1.64
[Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study]. Arch Bronconeumol (2004) 1.62
Emergency call service. J R Coll Gen Pract (1976) 1.56
The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med (2006) 1.54
[A contagiousness study in 3071 familial contacts of tuberculosis patients]. Med Clin (Barc) (1997) 1.54
Results of a case-detection programme for alpha1-antitrypsin deficiency in COPD patients. Eur Respir J (2005) 1.51
Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J (2002) 1.48
Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer (1999) 1.48
Sputum periostin in patients with different severe asthma phenotypes. Allergy (2015) 1.47
The haematuria clinic. BMJ (1994) 1.46
Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest (2001) 1.44
[Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients]. Gynecol Obstet Fertil (2000) 1.44
Strongyloides stercoralis infection in renal transplant recipients. Br Med J (Clin Res Ed) (1981) 1.43
[Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease]. Arch Bronconeumol (2006) 1.43
Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy. Eur J Health Econ (2010) 1.41
Pulmonary function in chronic renal failure: effects of dialysis and transplantation. Thorax (1991) 1.41
[Ambulatory oxygen therapy via a transtracheal catheter]. Arch Bronconeumol (1996) 1.39
[Pneumology residents trained in Catalonia (1989-1993)]. Med Clin (Barc) (1996) 1.38
[Effects of sleep on chronic obstructive pulmonary disease]. Med Clin (Barc) (1992) 1.37
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther (2000) 1.33
Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J (2006) 1.28
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur Respir J (2009) 1.24
Pressor response after intravenous labetalol. Br Med J (1977) 1.24
The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) (2002) 1.23
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax (2003) 1.22
Clinical findings of the second 1000 UK Gulf War veterans who attended the Ministry of Defence's Medical Assessment Programme. J R Army Med Corps (2001) 1.15
Problems and issues with door-to-door, two-phase surveys: an illustration from central Spain. Neuroepidemiology (2001) 1.14
Reversible encephalopathy and acute renal failure after cephaloridine. Br Med J (1970) 1.14
Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment. Chest (1996) 1.13
Clofibrate-induced myopathy and neuropathy. Lancet (1976) 1.13
The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories. Eur Respir J (2011) 1.11
Increased incidence of malignancy in chronic renal failure. Nephron (1977) 1.11
Raised complement in nephritis: prognostic significance. Lancet (1972) 1.09
Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer (2004) 1.08
Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol (1998) 1.07
[Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation]. Arch Bronconeumol (1999) 1.06
[Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease]. Arch Bronconeumol (2001) 1.06
Calcium released from intracellular stores inhibits GABAA-mediated currents in ganglion cells of the turtle retina. J Neurophysiol (1998) 1.04
Prevalence of stroke and transient ischemic attack in three elderly populations of central Spain. Neuroepidemiology (2008) 1.03
Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication. Aliment Pharmacol Ther (2003) 1.02
IgG subclass deficiencies associated with bronchiectasis. Am J Respir Crit Care Med (1996) 1.02
Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. Eur Respir J (2002) 1.02
[Recommendations for the care of the patient with chronic obstructive pulmonary disease]. Arch Bronconeumol (2001) 1.01
Removal of metronidazole by haemodialysis. Br J Surg (1980) 1.00
Time to scrap creatinine clearance? Br Med J (Clin Res Ed) (1986) 0.99
Sleep apnea and hypertension. Chest (2000) 0.97
Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol (2000) 0.97
Prognostic considerations in the management of left ventricular aneurysms. Ann Thorac Surg (1977) 0.97
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy. Aliment Pharmacol Ther (2000) 0.96
PACAP is an endogenous protective factor-insights from PACAP-deficient mice. J Mol Neurosci (2012) 0.95
The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: the VITAE study. Ventriculo Izquierdo Tension Arterial España. J Hypertens (1999) 0.93
Ethnic comparison of the association of undiagnosed diabetes with obesity. Int J Obes (Lond) (2009) 0.93
Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J (Clin Res Ed) (1988) 0.93
Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia (2007) 0.92
Multidrug-resistant tuberculosis caused by 'W'-related strains in three immunocompetent foreign-born patients. Int J Tuberc Lung Dis (1999) 0.92
Somatostatin modulates voltage-gated K(+) and Ca(2+) currents in rod and cone photoreceptors of the salamander retina. J Neurosci (2000) 0.91
Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study. Rev Esp Enferm Dig (2001) 0.91
Acute interstitial nephritis complicating Legionnaires' Disease. Clin Nephrol (1981) 0.90
Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics. Thorax (2006) 0.89
Neuropathic calcaneal tuberosity avulsion fractures. Clin Orthop Relat Res (1993) 0.89